Non-steroidal anti-inflammatory drug-induced renal failure: A brief review of the role of cyclo-oxygenase isoforms

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 1, 1998, Pages 79-82

  Venturini, Catherine M ^a   Isakson, Peter ^a   Needleman, Philip ^a  

^a MONSANTO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

ACUTE KIDNEY FAILURE; DRUG DEGRADATION; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; KIDNEY FUNCTION; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOGS; HUMANS; ISOENZYMES; KIDNEY; KIDNEY FAILURE, ACUTE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS;

EID: 0031975062     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199801000-00013     Document Type: Review

References (23)

1. Welton A. Renal effects of over-the-counter analgesics. J Clin Pharmacol 1995; 35:454-463.
2. Breyer MD, Badr KF. Arachidonic acid metabolites and the kidney. In: Brenner BM (editor): The kidney, volume 1, 5th edn. Philadelphia: Saunders & Co; 1996:754-788.
3. Terragno NA, Terrango DA, McGiff JC. Contribution of prostaglandins to the renal circulation in conscious, anesthetized and laparotomized dogs. Circ Res 1976; 40:590-595.
4. Blasingham CM, Nasjletti A. Differential renal effects of cyclooxygenase inhibition in sodium-replete and sodium-deprived dogs. Am J Physiol 1980; 239:F360-F365.
5. DeForest LM, Davis JO, Freeman RH, Seymour AA, Rowe BP, Williams GM, Davis TP. Effects of indomethacin and meclofenamate on renin release and renal hemodynamic function during chronic sodium depletion in conscious dogs. Circ Res 1980; 47:99-107.
6. Venturini CM, Womack CR, Leahy KM, McMahon EG. The non-steroidal anti-inflammatory drug ketorolac reduced renal function and renal blood flow in salt and volume depleted dogs [Abstract]. FASEB J 1997; 11:459A.
7. Bennett WM, Henrich WL, Stoff JS. The renal effects of non-steroidal anti-inflammatory drugs: summary and recommendations. Am J Kidney Dis 1996; 28 (Suppl 1):356-362.
8. Cook ME, Wallin JD, Thakur VD, Kadowitz PJ, McNamara DB, Garcia MM, et al. Comparative effects of nabutmetone, sulindac and ibuprofen on renal function. J Rheumatol 1997; 24:1137-1144. This study compares the effects of three NSAIDs in 17 women taking anti-hypertensive drugs and evaluates the renal effects seen in these patients.
9. Dinchul JE, Carr BD, Focht RJ, Johnson JJ, Jaffee BD, Covington MB, et al. Renal abnormalities and altered inflammatory response in mice lacking cyclooxygenase-2. Nature 1995; 378:406-409.
10. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994; 91:12013-12017.
11. 2 synthase (Cyclooxygenase) in human monocytes. J Biol Chem 1995; 265:16737-16740.
12. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, Seibert K. Expression and selective inhibition of the constitutive and inducible forms of human Cyclooxygenase. Biochem J 1995; 305:479-484.
13. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994; 94:2504-2510. This study demonstrates the presence of COX-2 in the macula densa of rat kidneys, and subsequent upregulation of this protein after salt depletion.
14. Guan Y, Chang M, Cho W, Zhang Y, Redha R, Davis L, et al. Cloning, expression and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. Am J Physiol 1997; 273:F18-F26.
15. Gresham AK, Venturini CM, Edwards D, Ornberg RL. COX-2 expression is induced in the macula densa in volume depleted dogs [Abstract]. FASEB J 1997; 11:A461. This report shows that COX-2 is also present in the macula densa of kidneys, and is upregulated after salt depletion.
16. Davis JO, Freeman RH. Mechanisms regulating renin release. Physiol Rev 1976; 56:1-56.
17. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, Carretero OA. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension 1997; 29:297-301. In this work, the authors demonstrated an inhibition of renal renin content in kidney slices taken from salt-depleted rats treated with a specific COX-2 inhibitor. These data indicate a role for COX-2 in the increased renin production in response to salt depletion.
18. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993; 330:156-160.
19. Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implications for renal function. Am J Physiol 1997; 272:F460-F468. These authors examined human kidney COX-1 and COX-2 profiles. They found no COX-2 in the macula densa of normal human kidneys.
20. Khan N, Brassard J, Kats A, Bunch R, Venturini CM, Marris D, Alden C. Renal profile of cyclooxygenase-1 and cyclooxygenase-2 in dogs, rats, human, and non-human primates. Toxicol Pathol 1997 (in press).
21. Service RF. Closing in on a stomach sparing aspirin substituten [Abstract]. Science 1996; 273:1660A.
22. Lipsky PE, Isakson PC. Outcome of specific COX-2 inhibition in RA. J Rheumatology 1997; 24 (Suppl 49):9-14.
23. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter PD, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of SC-58635 (celecoxib). J Med Chem 1997; 40:1347-1365.